Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23818695 | 0.94 | TMPRSS2 (0.34) | TMPRSS2MAPK14 | |
| SCHEMBL23818650 | 0.89 | POLRMT (0.35) | — | |
| SCHEMBL23819300 | 0.83 | POLRMT (0.36) | TMPRSS2 | |
| SCHEMBL23819157 | 0.82 | POLRMT (0.34) | — | |
| SCHEMBL23818850 | 0.82 | POLRMT (0.34) | — | |
| SCHEMBL23818943 | 0.82 | POLRMT (0.35) | — | |
| SCHEMBL26331355 | 0.81 | TMPRSS2 (0.31) | TMPRSS2 | |
| SCHEMBL23818539 | 0.80 | POLRMT (0.34) | — | |
| SCHEMBL23818585 | 0.79 | TMPRSS2 (0.32) | TMPRSS2 | |
| SCHEMBL26295855 | 0.79 | POLRMT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284670-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284670-A1 | ANTIVIRAL COMPOUNDS | MAVS, HAVCR2, ZC3HAV1 | TMPRSS2 324/4885MAPK14 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.